We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+5.8%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$42.2B
AUM Growth
-$360M
Cap. Flow
-$2.32B
Cap. Flow %
-5.5%
Top 10 Hldgs %
7.6%
Holding
2,945
New
147
Increased
1,226
Reduced
1,320
Closed
236

Sector Composition

Rank Sector Weight
1 Technology 14.48%
2 Financials 12.95%
3 Healthcare 12.03%
4 Industrials 10.73%
5 Consumer Discretionary 10.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHM icon
151
Pultegroup
PHM
$25.7B
$71.5M 0.17%
2,150,291
+520,436
+32% +$16.2M
NUE icon
152
Nucor
NUE
$60.5B
$71.1M 0.17%
1,118,852
+222,246
+25% +$13M
HOLX
153
DELISTED
Hologic
HOLX
$71.1M 0.17%
1,662,053
+523,654
+46% +$20.9M
DIS icon
154
Walt Disney
DIS
$172B
$70.8M 0.17%
658,268
+19,558
+3% +$2.01M
CI icon
155
Cigna
CI
$79.6B
$70.5M 0.17%
346,890
+12,410
+4% +$2.47M
NEE icon
156
NextEra Energy
NEE
$186B
$70.4M 0.17%
1,804,136
-22,520
-1% -$869K
XYL icon
157
Xylem
XYL
$29.7B
$70.4M 0.17%
1,032,707
-203,337
-16% -$13.5M
WU icon
158
Western Union
WU
$2.58B
$70.2M 0.17%
3,692,167
+218,317
+6% +$4.28M
EQIX icon
159
Equinix
EQIX
$102B
$70M 0.17%
154,422
+39,558
+34% +$18.3M
CLX icon
160
Clorox
CLX
$12.1B
$69.9M 0.17%
469,627
-3,800
-0.8% -$517K
INCY icon
161
Incyte
INCY
$26B
$69.7M 0.17%
735,510
+106,468
+17% +$11.1M
TSN icon
162
Tyson Foods
TSN
$21.5B
$69.6M 0.16%
858,602
-189,260
-18% -$14.5M
CB icon
163
Chubb
CB
$141B
$69.4M 0.16%
475,198
+13,282
+3% +$1.98M
VTRS icon
164
Viatris
VTRS
$20.8B
$69.3M 0.16%
1,637,178
+79,902
+5% +$3.05M
PNR icon
165
Pentair
PNR
$10.8B
$69.1M 0.16%
1,456,981
-76,339
-5% -$3.57M
SBUX icon
166
Starbucks
SBUX
$118B
$69.1M 0.16%
1,202,816
-402,824
-25% -$22.8M
ACN icon
167
Accenture
ACN
$101B
$68.8M 0.16%
449,363
+8,447
+2% +$1.22M
MKC icon
168
McCormick & Company Non-Voting
MKC
$13.9B
$68.6M 0.16%
1,345,390
-11,710
-0.9% -$583K
EVHC
169
DELISTED
Envision Healthcare Holdings Inc
EVHC
$68.4M 0.16%
1,979,973
+1,156,381
+140% +$40.4M
LOW icon
170
Lowe's Companies
LOW
$122B
$68.4M 0.16%
735,724
+45,593
+7% +$3.77M
MPC icon
171
Marathon Petroleum
MPC
$89.3B
$68.3M 0.16%
1,035,831
-73,817
-7% -$4.52M
KMB icon
172
Kimberly-Clark
KMB
$37.5B
$68.2M 0.16%
565,157
+8,816
+2% +$1.03M
UNM icon
173
Unum
UNM
$14B
$68.2M 0.16%
1,242,010
-162,505
-12% -$8.72M
HRL icon
174
Hormel Foods
HRL
$14.1B
$67.8M 0.16%
1,863,224
-125,595
-6% -$4.22M
IP icon
175
International Paper
IP
$23.3B
$67.4M 0.16%
1,229,215
+75,833
+7% +$4.07M

Similar funds

Guggenheim Capital's Q4 2017 Portfolio in Review

As of Q4 2017, Guggenheim Capital held 2,945 positions worth $42.2B, down 0.85% from $42.6B the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.

Guggenheim Capital withdrew a net $2.32B in Q4 2017, closing 236 positions and reducing 1,320 holdings. Its most notable exit was CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF, an estimated $84.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Guggenheim Capital opened a new position in iShares China Large-Cap ETF worth $18M.

  • Guggenheim Capital's largest Q4 2017 buy was iShares China Large-Cap ETF: 389,755 shares worth $18M.
  • Guggenheim Capital added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2017, an estimated $859M increase.
  • Guggenheim Capital's biggest Q4 2017 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $106M.
  • Guggenheim Capital fully exited CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF in Q4 2017, selling an estimated $84.5M.
  • Guggenheim Capital's ten largest holdings make up 7.6% of its $42.2B portfolio in Q4 2017.
  • Guggenheim Capital opened 147 new positions and closed 236 in Q4 2017.
  • Guggenheim Capital's portfolio value fell 0.85% quarter-over-quarter to $42.2B.

Based on Guggenheim Capital's 13F filing for Q4 2017, filed 14 Feb 2018.